Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1087

1.

Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.

Santana TA, Trufelli DC, de Matos LL, Cruz FM, Del Giglio A.

Support Care Cancer. 2014 Aug 22. [Epub ahead of print]

PMID:
25145507
[PubMed - as supplied by publisher]
2.

Modeling, Molecular Dynamics Simulation and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs.

Feng Z, Alqarni MH, Yang P, Tong Q, Chowdhury A, Wang L, Xie XQ.

J Chem Inf Model. 2014 Aug 20. [Epub ahead of print]

PMID:
25141027
[PubMed - as supplied by publisher]
3.

Cannabinoids as therapeutic agents in cancer: current status and future implications.

Chakravarti B, Ravi J, Ganju RK.

Oncotarget. 2014 Aug 30;5(15):5852-72.

PMID:
25115386
[PubMed - in process]
Free Article
4.

Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2.

Yang L, Li Y, Ren J, Zhu C, Fu J, Lin D, Qiu Y.

Int J Mol Sci. 2014 Aug 6;15(8):13637-48. doi: 10.3390/ijms150813637.

PMID:
25101848
[PubMed - in process]
Free Article
5.

CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINE-ACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1.

Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B.

Biochem Pharmacol. 2014 Jul 25. pii: S0006-2952(14)00420-1. doi: 10.1016/j.bcp.2014.07.014. [Epub ahead of print]

PMID:
25069049
[PubMed - as supplied by publisher]
6.

Molecular imaging of human tumor cells that naturally overexpress type 2 cannabinoid receptors using a quinolone-based near-infrared fluorescent probe.

Wu Z, Shao P, Zhang S, Ling X, Bai M.

J Biomed Opt. 2014 Jul;19(7):76016. doi: 10.1117/1.JBO.19.7.076016.

PMID:
25036213
[PubMed - in process]
7.

Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor.

Chen X, Zheng C, Qian J, Sutton SW, Huang Z, Jianxin LV, Liu C, Zhou N.

Curr Mol Pharmacol. 2014 Jul 14. [Epub ahead of print]

PMID:
25023974
[PubMed - as supplied by publisher]
8.

The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.

Cipriano M, Gouveia-Figueira S, Persson E, Nording M, Fowler CJ.

BMC Res Notes. 2014 Jul 10;7:441. doi: 10.1186/1756-0500-7-441.

PMID:
25012825
[PubMed - in process]
Free PMC Article
9.

Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.

Afzal O, Kumar S, Kumar R, Firoz A, Jaggi M, Bawa S.

Bioorg Med Chem Lett. 2014 Aug 15;24(16):3986-96. doi: 10.1016/j.bmcl.2014.06.029. Epub 2014 Jun 19.

PMID:
25011912
[PubMed - in process]
10.

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation.

Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S.

Transl Psychiatry. 2014 Jul 8;4:e408. doi: 10.1038/tp.2014.53.

PMID:
25004388
[PubMed - in process]
Free PMC Article
11.

Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet.

Donat CK, Fischer F, Walter B, Deuther-Conrad W, Brodhun M, Bauer R, Brust P.

Acta Neurobiol Exp (Wars). 2014;74(2):197-210.

PMID:
24993629
[PubMed - in process]
Free Article
12.

Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells.

Ramer R, Fischer S, Haustein M, Manda K, Hinz B.

Biochem Pharmacol. 2014 Sep 15;91(2):202-16. doi: 10.1016/j.bcp.2014.06.017. Epub 2014 Jun 26.

PMID:
24976505
[PubMed - in process]
13.

Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling.

Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C.

J Biol Chem. 2014 Aug 8;289(32):21960-72. doi: 10.1074/jbc.M114.561761. Epub 2014 Jun 18.

PMID:
24942731
[PubMed - in process]
14.

Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.

Häggström J, Cipriano M, Forshell LP, Persson E, Hammarsten P, Stella N, Fowler CJ.

Prostate. 2014 Aug;74(11):1107-17. doi: 10.1002/pros.22827. Epub 2014 Jun 9.

PMID:
24913716
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.

Murase R, Kawamura R, Singer E, Pakdel A, Sarma P, Judkins J, Elwakeel E, Dayal S, Martinez-Martinez E, Amere M, Gujjar R, Mahadevan A, Desprez PY, McAllister SD.

Br J Pharmacol. 2014 Jun 9. doi: 10.1111/bph.12803. [Epub ahead of print]

PMID:
24910342
[PubMed - as supplied by publisher]
16.

Cardiovascular effects of current and future anti-obesity drugs.

Comerma-Steffensen S, Grann M, Andersen CU, Rungby J, Simonsen U.

Curr Vasc Pharmacol. 2014 May;12(3):493-504.

PMID:
24846238
[PubMed - in process]
17.

Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

Hermanson DJ, Gamble-George JC, Marnett LJ, Patel S.

Trends Pharmacol Sci. 2014 Jul;35(7):358-67. doi: 10.1016/j.tips.2014.04.006. Epub 2014 May 18. Review.

PMID:
24845457
[PubMed - indexed for MEDLINE]
18.

Cancer risks from diabetes therapies: Evaluating the evidence.

Li C, Kong D.

Pharmacol Ther. 2014 Oct;144(1):71-81. doi: 10.1016/j.pharmthera.2014.05.006. Epub 2014 May 15. Review.

PMID:
24844968
[PubMed - as supplied by publisher]
19.

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

Davis MP.

Expert Opin Investig Drugs. 2014 Aug;23(8):1123-40. doi: 10.1517/13543784.2014.918603. Epub 2014 May 16.

PMID:
24836296
[PubMed - in process]
20.

Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy volunteers.

Walter C, Oertel BG, Ludyga D, Ultsch A, Hummel T, Lötsch J.

Br J Clin Pharmacol. 2014 May 6. doi: 10.1111/bcp.12415. [Epub ahead of print]

PMID:
24802974
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk